Annual Report

The report describes a strong 2011 performance, with Group revenue increasing 25.6% to $918.0 million. It highlights the acquisition of Baxter Healthcare's MSI business, which added $120.3 million of revenue to Injectables in eight months and nearly doubled the business's scale. In sustainability, the company reports renewed ISO 14001:2004 certification in Jordan and Egypt and continued environmental reporting and resource-efficiency initiatives.